Background
Methods
Study context
Information sources and search strategies
Data selection
-
Targeted women diagnosed with cancer and offered fertility preservation options,
-
Described fertility problems as a consequence of cancer treatment,
-
Described fertility preservation options and consequences
-
Contained an explicit statement to consider fertility preservation options before cancer treatment.
-
Raised awareness of the link between cancer treatment and fertility problems
-
Contained explicit guidance on what fertility preservation options to mention to women diagnosed with cancer
-
Explained the links between the fertility and cancer management pathways
-
Provided explicit guidance on how to support women’s choices about fertility preservation options in the context of their cancer care.
Data extraction
-
Characteristics: type of ‘e-resource’ (internet-delivered, internet-adapted, internet-available) [35], title, publisher, year of publication and of the updated year, country, authors, funders, location (URL), length, stated purpose resource.
-
Quality indicators: Flesch readability formula [3] was used to measure comprehensibility of leaflet (70–79 fairly easy; 60–69 standard; 50–59 fairly difficult; 30–50 difficult; 0–29 confusing), endorsed by third party, developed systematically, listed evidence used to inform content.
-
Describes health problem: label and symptoms, cause, time-line, consequences, cure and/or control, and emotional responses to a) cancer, b) fertility / infertility, and c) cancer-related infertility.
-
Describes treatments: label /procedure, eligibility, prognosis, side effects short term, side effects long term for cancer treatment (chemo/ radio/ hormone therapy, surgery), fertility preservation treatments (egg/ embryo/ ovarian freezing, ovarian suppression/ shielding), and/or infertility treatments (in vitro fertilisation, adoption/ fostering, surrogacy).
-
Signposts illness-wellness trajectory: care pathways; quality of life.
-
Decision architecture to boost/ bias thinking: trade-offs between options; decision picture; decision guidance; other’s values/ stories; risk presentation; treatment preference.
-
Health service engagement: prompts to prepare for consultations, friends and families; diagrams/ guidance to prepare for procedures; signposting to other information.
Data synthesis and analysis
Results
Guideline title | Organisation (Country) | Year of publication | Year guideline identified | Eligibility criteria 1a | Eligibility criteria 2a | Eligibility criteria 3a | Eligibility criteria 4a |
---|---|---|---|---|---|---|---|
Fertility preservation for AYAs diagnosed with cancer: Guidance for health professionals | The clinical practice guideline portal (Australia and New Zealand) | 2011 | 2015 & 2017 | x | |||
South Australian Gynaecological Cancer Care Pathway Optimising Outcomes for Women with Gynaecological Cancer | The clinical practice guideline portal (Australia and New Zealand) | 2014 | 2015 & 2017 | x | |||
Clinical practice guidelines for the management and support of younger women with breast cancer | National health and medical research council (Australia and New Zealand) | 2004 | 2015 & 2017 | x | |||
Clinical practice guidelines for the management of women with epithelial ovarian cancer | National health and medical research council (Australia and New Zealand) | 2004 | 2015 & 2017 | x | |||
Clinical practice guidelines for the psychosocial care of adults with cancer | National health and medical research council (Australia and New Zealand) | 2003 | 2015 & 2017 | x | |||
For the prevention, early Detection and management of colorectal cancer | National health and medical research council (Australia and New Zealand) | 2005 | 2015 & 2017 | x | |||
The effects of cancer treatment on reproductive functions. Guidance on management | The Royal College of Physicians (UK) | 2007 | 2015 & 2017 | x | |||
Fertility Sparing Treatments in Gynaecological Cancers | Royal College of Obstetricians and Gynaecologists (UK) | 2013 | 2015 & 2017 | x | |||
Pregnancy and Breast Cancer | Royal College of Obstetricians and Gynaecologists (UK) | 2011 | 2015 & 2017 | x | |||
Long term follow up of survivors of childhood cancer | SIGN (UK) | 2013 | 2015 & 2017 | x | x | ||
Management of epithelial ovarian cancer | SIGN (UK) | 2013 | 2015 & 2017 | x | x | ||
Management of cervical cancer | SIGN (UK) | 2008 | 2015 & 2017 | x | |||
Gynaecological cancer: guidance for nursing staff | Royal College of Nursing (UK) | 2005 | 2015 & 2017 | x | |||
Classical Hodgkin’s Lymphoma; 1st Line | British Committee for Standards in Haematology (UK) | 2014 | 2015 & 2017 | x | x | ||
For the diagnosis and Management of lymphoma | National Health and Medical Research Council (UK) | 2005 | 2015 & 2017 | x | x | ||
Fertility problems and assessment | NICE (UK) | 2014 | 2015 & 2017 | x | x | ||
Fertility Pathway | NICE (UK) | 2014 | 2015 & 2017 | x | x | x | |
Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma | British Committee for Standards in Haematology (UK) | 2015 | 2015 & 2017 | x | |||
Cancer, fertility and pregnancy | ESMO (European) | 2010 | 2015 & 2017 | x | |||
Cervical Cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | ESMO (European) | 2012 | 2015 & 2017 | x | |||
Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | ESMO (European) | 2012 | 2015 & 2017 | x | |||
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | ESMO (European) | 2015 | 2015 & 2017 | x | x | ||
Preservation of Fertility in Paediatric and Adolescent Patients With Cancer | American Academy of Paediatrics (USA) | 2009 | 2015 & 2017 | x | x | ||
ACR Appropriateness Criteria pre-treatment planning of invasive cancer of the cervix | American College of Radiology - Medical Specialty Society (USA) | 2011 | 2015 & 2017 | x | |||
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients | American Society of Clinical Oncology (USA) | 2006 | 2015 & 2017 | x | x | x | |
Cancer of the uterine cervix | Alberta health (USA) | 2014 | 2015 & 2017 | x | |||
Epithelial ovarian, fallopian tube, and primary peritoneal cancer | Alberta health (USA) | 2012 | 2015 & 2017 | x | |||
Ovarian germ cell tumours | Alberta health (USA) | 2013 | 2015 & 2017 | x | |||
Lymphoma | Alberta health (USA) | 2014 | 2015 & 2017 | x | |||
Management of gynaecologic issues in women with breast cancer | American College of Obstetricians and Gynecologists (USA) | 2013 | 2015 & 2017 | x | |||
Breast Cancer: Management and Follow-up | Clinical Practice Guidelines and Protocols in British Columbia (Canada) | 2013 | 2015 & 2017 | x | x |
Study No. | Source | Resource Title | Organisation (Country) | Resource Typea | Target Group | Cancer Type | Year resource identified | Year of publication (updated) | No. pages | Readability Flesch Score [2] |
---|---|---|---|---|---|---|---|---|---|---|
1 | Google | Cancer Treatment Fertility- Information for Women | Macmillan Cancer Support (UK) | Internet- available | Adult | Any cancer | 2015 & 2017 | 2013 (2016) | 50 | 55 |
2 | Google | Fertility care for Women Diagnosed with Cancer | Central Manchester University Hospital- St Mary’s Hospital (UK) | Internet- available | Adult | Any cancer | 2015 & 2017 | 2013 | 16 | 48 |
3 | Google | Save My Fertility: Fertility Preservation for Women Diagnosed with Cancer | The Onco-fertility Consortium (USA) | Internet- delivered, Internet- available & Mobile App | Adult & TYA | Any cancer | 2015 &2017 | 2011 | 5 | 35 |
4 | Google | Fertility and Breast Cancer Treatments | Breast Cancer Care (UK) | Internet- available | Adult | Breast | 2015 &2017 | 2014 (2017) | 22 | 52 |
5 | Google | Fertility and Women with Cancer | American Cancer Society (USA) | Internet- delivered & Internet- available | Adult & TYA | Any cancer | 2016 & 2017 | 2013 | 25 | 48 |
6 | Google | Fertility and Pregnancy Issues During and After Breast Cancer | Breast Cancer.org (USA) | Internet- delivered | Adult | Breast | 2015 & 2017 | 2015 | 21 | 57 |
7 | Google | Fertility and Cancer: A Guild for People With Cancer, Their Friends and Families | Cancer Council (Australia) | Internet- available | Adult & TYA | Any cancer | 2015 & 2017 | 2014 (2016) | 86 | 45 |
8 | Google | Breast Cancer and Fertility | Europe Donna Ireland (Ireland) | Internet- available | Adult | Breast | 2015 & 2017 | 2008 | 16 | 48 |
9 | Google | Oncofertility | Flinders Fertility (Australia) | Internet- available | Adult | Any cancer | 2015 & 2017 | 2013 | 14 | 32 |
10 | Google | Can I Still Have Children? | Melbourne IVF and Royal Women’s Hospital (Australia) | Internet- available | Adult | Any cancer | 2015 & 2107 | 2013 | 20 | 41 |
11 | Google | Fertility Concerns and Preservation for Women | Cancer.net (USA) | Internet- delivered | Adult | Any cancer | 2015 & 2017 | 2014 | 5 | 27 |
12 | Google | Fertility Preservation: Options for Women Who Are Starting Cancer Treatment | Memorial Sloan- Kettering Cancer Centre (USA) | Internet- available | Adult | Any cancer | 2015 & 2017 | 2015 | 14 | 47 |
13 | Google | Fertility | New Zealand Breast Cancer Foundation (New Zealand) | Internet- delivered | Adult | Breast | 2015 & 2017 | 2013 | 2 | 47 |
14 | Google | Caring for Adolescents and Young Adults | NCCN guidelines for Patients(USA) | Internet- available & Internet- delivered | TYA & Parents | Any cancer | 2015 & 2017 | 2013 | 118 | 53 |
15 | Google | Fertility Preservation in Cervical Cancer | North London Gynaecological Cancer Network (UK) | Internet- available | Adult | Gynaecological cancers | 2015 & 2017 | 2015 | 10 | 42 |
16 | Google | Fertility and Cancer | New life (UK) | Internet- delivered | Adult | Any cancer | 2015 & 2017 | 2015 | 7 | 55 |
17 | Google | Fertility Preservation for Women with Cancer: FAQs | Walgreens (USA) | Internet- available | Adult | Any cancer | 2015 & 2017 | 2011 | 8 | 41 |
18 | Google | Fertility Options to Consider Before Treatment Begins and Parenthood Options After Cancer | Fertile Hope & Cleveland Clinic (USA) | Internet- available | Adult | Any cancer | 2015 & 2017 | 2005 | 12 | 49 |
19 | Google | Fertility Preservation | University of Iowa Hospitals and Clinics (USA) | Internet- available | Adult | Any cancer | 2015 & 2017 | 2013 | 21 | 48 |
20 | Google | Future Fertility: Preserving Fertility in Women with Cancer | University of New South Wales, Onco-fertility Consortium, Prince of Wales Hospital (Australia) | Internet- delivered & Internet- available | Adult | Any cancer | 2015 & 2017 | 2015 | 52 | 58 |
21 | Google | Fertility Facts | Lymphoma and Leukaemia Society (USA) | Internet- available | TYA | Lymphoma and Leukaemia | 2015 & 2017 | 2015 | 7 | 41 |
22 | DALI database | Breast cancer and having children | Leiden University Medical Centre/ Pink Ribbon (Dutch) | Internet- adapted | Adult | Breast | 2015 & 2017 | 2012 | 31 | 47 |
23 | Expert contacts | Learning About Cancer and Fertility: A Guide for Parents of Young Girls | North western University/ Onco-fertility Consortium (USA) | Internet- available | Parents | Any cancer | 2015 & 2017 | 2011 | 24 | 55 |
24 | Expert contacts | Fertility-related choices: A decision aid for younger women with breast cancer | University of Melbourne/ Breast Cancer Network/ Prince of Wales Hospital (Australia) | Internet- available | Adult | Breast | 2015 & 2017 | 2013 (2016) | 57 | 78 |
Development Process Item | Study Number of Resource | Number of resources including component | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | ||
Publishers | |||||||||||||||||||||||||
Service providers | x | x | x | x | x | x | x | 7 | |||||||||||||||||
Charity organisation | x | x | x | x | x | x | x | x | x | 9 | |||||||||||||||
Mixed (service, charity, academic) | x | x | x | x | x | x | 6 | ||||||||||||||||||
Pharmaceutical companies | x | x | 2 | ||||||||||||||||||||||
Stakeholders | |||||||||||||||||||||||||
Communication or decision scientist | x | x | 2 | ||||||||||||||||||||||
Charity representative | x | x | x | x | x | 5 | |||||||||||||||||||
Patient or advocacy groups | x | x | x | x | x | 5 | |||||||||||||||||||
Fertility professional | x | x | x | x | x | x | x | x | 8 | ||||||||||||||||
Cancer professionals | x | x | x | x | x | x | x | x | x | x | 10 | ||||||||||||||
Primary healthcare professionals | x | x | x | x | x | x | x | 7 | |||||||||||||||||
Pharmaceutical organisation | x | 1 | |||||||||||||||||||||||
Applied researchers | x | x | x | x | 4 | ||||||||||||||||||||
Health care professional organisation | x | x | x | x | x | x | 6 | ||||||||||||||||||
Endorsement Referenced In Resource | |||||||||||||||||||||||||
Information standard | x | x | 2 | ||||||||||||||||||||||
Professional body | 0 | ||||||||||||||||||||||||
Patient advocacy | x | x | 2 | ||||||||||||||||||||||
IPDAS endorsement | 0 | ||||||||||||||||||||||||
Evidence-Base Referenced In Resource | |||||||||||||||||||||||||
Evidence-based publication in resource | x | x | x | x | x | x | x | x | x | x | 10 | ||||||||||||||
Quality Publication About Resource | |||||||||||||||||||||||||
Publication of development/ evaluation | x | x | x | 3 | |||||||||||||||||||||
Located on recognised repository (DALI) | x | x | x | 3 |
Meeting minimum standards for patient decision aid resources
IPDAS Checklist Item | Study Number of Resources Including Component | Number of resources including component | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | ||
1. Describes health condition for index decision | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 24 |
2. Explicitly describes the index decision being considered | x | x | x | x | x | x | 6 | ||||||||||||||||||
3. Describes the options | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 24 |
4. Describes positive features all options | x | x | x | 3 | |||||||||||||||||||||
5. Describes negative features all options | x | x | x | x | x | x | x | x | 8 | ||||||||||||||||
6. Describes what it is like to experience the psychosocial consequences of options | 0 | ||||||||||||||||||||||||
7. Shows negative and positive features of all options in equal detail (text amount, equal stats/ consequences) | x | x | 2 | ||||||||||||||||||||||
8 Cites evidence used or links to document | x | x | x | x | x | x | x | x | x | x | 10 | ||||||||||||||
9. Provides a publication date resource | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 14 | ||||||||||
10. Provides information about an update policy | x | x | x | x | x | x | x | x | x | x | 10 | ||||||||||||||
11. Provides information about uncertainty level around event /outcome probabilities | 0 | ||||||||||||||||||||||||
12. Provides information about the funding source used for development | x | x | x | x | x | x | x | 7 | |||||||||||||||||
Total score IPDAS (out of 12) | 5 | 6 | 5 | 6 | 6 | 3 | 4 | 4 | 3 | 4 | 3 | 4 | 2 | 6 | 3 | 2 | 7 | 4 | 4 | 3 | 2 | 8 | 5 | 8 |
Inclusion of components boosting or biasing informed decision-making
Cancer (16/24) | Fertility (14/24) | Infertility (13/24) | Cancer-Related Infertility (24/24) | |
---|---|---|---|---|
Label/symptom | 3 (13%) | 7 (29%) | 4 (17%) | 9 (38%) |
Timeline | 1 (4%) | 6 (25%) | 5 (21%) | 21 (88%) |
Cause | 2 (8%) | 11 (46%) | 2 (8%) | 14 (58%) |
Consequence | 15 (63%) | 3 (13%) | 5 (21%) | 19 (79%) |
Cure/control | 5 (21%) | 1 (4%) | 7 (29%) | 17 (71%) |
Cancer Treatment | Fertility Preservation Options | ||
---|---|---|---|
Chemotherapy | 23 (96%) | Egg freezing | 22 (92%) |
Radiotherapy | 23 (96%) | Embryo freezing | 23 (96%) |
Surgery | 17 (71%) | Ovarian tissue freezing | 21 (88%) |
Hormone therapy | 8 (33%) | Ovarian suppression | 13 (54%) |
Targeted therapy | 4 (17%) | ||
Ovarian suppression as part of cancer treatment | 5 (21%) | ||
Family Planning During Cancer | Infertility Treatment/ Family Planning After Cancer | ||
Contraception | 11 (46%) | Natural | 17 (71%) |
Assisted conception | 17 (71%) | ||
Surrogacy | 16 (67%) | ||
Adoption / fostering | 15 (63%) | ||
Contraception | 12 (50%) |
I/SDM Component | Study Number of Resources including Component | Number of resources including component | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | ||
1. Provides accurate information about all options (IDM) | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 19 | |||||
2. Helps people think about what matters to them about the options (IDM) | x | x | x | x | x | x | x | x | x | x | 10 | ||||||||||||||
3. Supports reasoning about all options without bias (IDM) | x | x | x | x | x | 5 | |||||||||||||||||||
4. Presents figures in ways to support understanding (IDM) | x | x | 2 | ||||||||||||||||||||||
5. Encourages people to trade-off their evaluations to make a choice (IDM) | x | x | 2 | ||||||||||||||||||||||
6. Encourages people to share reasoning with their health professionals (SDM) | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 19 | |||||
7. Focuses thinking about the decision in the context of their lifestyle (IDM) | x | 1 | |||||||||||||||||||||||
8. Places the decision in the context of a changing illness-health state (IDM) | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 21 | |||
9 Enables decision to be implemented within care pathway (SDM) | x | 1 | |||||||||||||||||||||||
10. Encourages comparisons between different decisions (IDM) | x | x | x | x | 4 | ||||||||||||||||||||
Total Judgement score (out of 10) | 2 | 2 | 3 | 4 | 3 | 4 | 5 | 2 | 3 | 3 | 2 | 5 | 2 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 7 | 5 | 8 |